FERNANDEZ RETANA, JORGE

FERNANDEZ RETANA, JORGE

CIENCIAS BIOMÉDICAS · Nivel 1

Desde 2022 es Member of the Academic Core en Master of Science in Micro and Nanotechnologies Polytechnic University of the Valley of Mexico

Perfil académico

Nombre JORGE FERNANDEZ RETANA
Área BIOLOGÍA Y QUÍMICA
Campo CIENCIAS BIOMÉDICAS
Disciplina BIOLOGÍA MOLECULAR
Especialidad MOLECULAR
CVU 104639
Institución
Dependencia SECRETARIA ACADEMICA
Entidad MEXICO
Nivel 1
Vigencia Inicio: 01/01/2023
Fin: 31/12/2027

Publicaciones ORCID

2023
Insulin‑like growth factor axis: A potential nanotherapy target for resistant cervical cancer tumors (Review) Oncology Letters
2022
Design and automation of an electrospinning system to prepare micro and nanofibers. Case study: elaboration of polymeric micro and nanofibers for vaginal drug delivery.
2019
Genes Involved in the Transcriptional Regulation of Pluripotency Are Expressed in Malignant Tumors of the Uterine Cervix and Can Induce Tumorigenic Capacity in a Nontumorigenic Cell Line. Stem cells international
Sodium-coupled monocarboxylate transporter is a target of epigenetic repression in cervical cancer. International journal of oncology
Intratype variants of the E2 protein from human papillomavirus type 18 induce different gene expression profiles associated with apoptosis and cell proliferation. Archives of virology
Correction to: Intratype variants of the E2 protein from human papillomavirus type 18 induce different gene expression profiles associated with apoptosis and cell proliferation (Archives of Virology, (2019), 164, 7, (1815-1827), 10.1007/s00705-018-04124-6) Archives of Virology
2017
Gene signature based on degradome-related genes can predict distal metastasis in cervical cancer patients. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Transcriptome studies reveal altered signaling pathways in cervical cancer Cervical Cancer
2016
Comprehensive transcriptome analysis identifies pathways with therapeutic potential in locally advanced cervical cancer. Gynecologic oncology
A microRNA expression signature for clinical response in locally advanced cervical cancer. Gynecologic oncology